Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sanofi receives approval for Soliqua, a combination agent to treat type 2 diabetes, in Japan

March 26, 2020

Multistep method wrests causality from GWAS

March 26, 2020

Brown fat activity without fat browning

March 25, 2020

U.S. complete response letter issued for empagliflozin for type 1 diabetes

March 23, 2020

Drink plenty of water: Sugar shortens lifespan via dehydration, not metabolic defects

March 23, 2020

New knockout mice models and gene replacement therapy for Barth syndrome

March 23, 2020

Lexicon announces early close-out of long-term outcome studies of sotagliflozin

March 20, 2020

Comprehensive look identifies insulin autoantigens

March 20, 2020

Northwestern University synthesizes new glucosylceramidase modulators

March 19, 2020

Organ microbiomes associated with diabetes risk

March 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...